Guthrie Medical Group, P.C.

Summary

Guthrie Medical Group, P.C. is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Lung Cancer, Breast Cancer, Ulcerative Colitis, Heart Failure, Non-Small Cell Lung Cancer and other specialties. Guthrie Medical Group, P.C. is involved with conducting 69 clinical trials across 98 conditions. There are 2 research doctors associated with this hospital, such as Sudhakar Sattur, MD and James Walsh, MD.

Top PIs

Clinical Trials running at Guthrie Medical Group, P.C.

Chronic Kidney Disease

Clostridium Difficile Infection

Breast Cancer

Chronic Renal Failure

Cardiovascular Disease

Diarrhea

Clostridium difficile infection

C. diff infection

Kidney Failure

Hemodialysis

InnAVasc Graft Implant

for Kidney Failure

The goal of the CSP-2002 clinical trial is to evaluate the safety and effectiveness of the InnAVasc Arteriovenous Graft (IG) for hemodialysis (HD) access in patients with end-stage renal disease (ESRD). The primary study endpoints are: Primary Effectiveness Endpoint: The proportion of subjects with secondary patency at 6 months. Primary Safety Endpoint: The incidence of device-related adverse events of special interest (AESIs) through 6 months. Participants will be asked to sign an informed consent form. Once enrolled, they will be assessed to receive the study graft implant and asked to participate in periodic follow-up visits and assessments through 2 years following implant.

Recruiting

1 award

N/A

7 criteria

Retatrutide

for Obesity

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.

Recruiting

1 award

Phase 3

2 criteria